First disease modifying treatment for Endometriosis
| Website | http://www.fimmcyte.com |
| Employees | 7 (2 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology |
| Keywords | Endometriosis Treatment, Womens Health, Innovative Therapies, Healthcare Innovation, Gynecological Care, Reproductive Health, Clinical Trials, Medical Breakthroughs, Pain Management, Hormonal Imbalance, Pharmaceutical Research, Womens Health Research, Advanced Therapies, Infertility Treatment, Pelvic Pain, Drug Development, Biotechnology, Menstrual Disorders |
| Competitors | Pall ForteBio LLC, Biosensors International Group, Ltd, QIAGEN, abcam, Cell Signaling Technology (CST), Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Magyarország Kft., Roche +46 more (view full list) |
Looking for a particular FimmCyte employee's phone or email?
Maureen Cronin is the Chief Medical Officer of FimmCyte.
2 people are employed at FimmCyte.